In the BioHarmony Drug Report Database
Nifedipine
Adalat, Adalat Cc, Procardia, Procardia Xl (nifedipine) is a small molecule pharmaceutical. Nifedipine was first approved as Adalat on 1982-01-01. It is used to treat hypertension, stable angina, and variant angina pectoris in the USA. It is known to target glycine receptor subunit beta, voltage-dependent L-type calcium channel subunit alpha-1C, voltage-dependent L-type calcium channel subunit alpha-1S, transient receptor potential cation channel subfamily M member 3, glycine receptor subunit alpha-3, glycine receptor subunit alpha-1, voltage-dependent L-type calcium channel subunit alpha-1D, voltage-dependent L-type calcium channel subunit alpha-1F, nuclear receptor subfamily 1 group I member 2, potassium voltage-gated channel subfamily A member 5, potassium voltage-gated channel subfamily C member 1, potassium voltage-gated channel subfamily A member 7, potassium voltage-gated channel subfamily A member 2, and potassium voltage-gated channel subfamily A member 1.
Trade Name
|
Adalat, Adalat Cc, Procardia, Procardia Xl |
|---|---|
Common Name
|
nifedipine |
ChEMBL ID
|
CHEMBL193 |
Indication
|
hypertension, stable angina, variant angina pectoris |
Drug Class
|
Phenylpyridine vasodilators (nifedipine type) |
Image (chem structure or protein)